Dietary L-Tyrosine supplementation in nemaline myopathy

Monique M. Ryan, Catherine Sy, Sian Rudge, Carolyn Ellaway, David Ketteridge, Laurence G. Roddick, Susan T. Iannaccone, Andrew J. Kornberg, Kathryn N. North

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Nemaline myopathy is defined by the presence of nemaline bodies, or rods, on muscle biopsy. Facial and bulbar weakness in nemaline myopathy cause chewing and swallowing difficulties, recurrent aspiration, and poor control of oral secretions. This article discusses 5 patients (4 infants and 1 adolescent) with nemaline myopathy who received dietary supplementation with L-tyrosine (250 to 3000 mg/day). All 4 infants were reported to have an initial decrease in sialorrhoea and an increase in energy levels. The adolescent showed improved strength and exercise tolerance. No adverse effects of treatment were observed. Dietary tyrosine supplementation may improve bulbar function, activity levels, and exercise tolerance in nemaline myopathy.

Original languageEnglish (US)
Pages (from-to)609-613
Number of pages5
JournalJournal of Child Neurology
Volume23
Issue number6
DOIs
StatePublished - Jun 2008

Fingerprint

Nemaline Myopathies
Tyrosine
Exercise Tolerance
Dietary Supplements
Sialorrhea
Mastication
Deglutition
Biopsy
Muscles

Keywords

  • Myopathy
  • Nemaline
  • Sialorrhoea
  • Tyrosine

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Ryan, M. M., Sy, C., Rudge, S., Ellaway, C., Ketteridge, D., Roddick, L. G., ... North, K. N. (2008). Dietary L-Tyrosine supplementation in nemaline myopathy. Journal of Child Neurology, 23(6), 609-613. https://doi.org/10.1177/0883073807309794

Dietary L-Tyrosine supplementation in nemaline myopathy. / Ryan, Monique M.; Sy, Catherine; Rudge, Sian; Ellaway, Carolyn; Ketteridge, David; Roddick, Laurence G.; Iannaccone, Susan T.; Kornberg, Andrew J.; North, Kathryn N.

In: Journal of Child Neurology, Vol. 23, No. 6, 06.2008, p. 609-613.

Research output: Contribution to journalArticle

Ryan, MM, Sy, C, Rudge, S, Ellaway, C, Ketteridge, D, Roddick, LG, Iannaccone, ST, Kornberg, AJ & North, KN 2008, 'Dietary L-Tyrosine supplementation in nemaline myopathy', Journal of Child Neurology, vol. 23, no. 6, pp. 609-613. https://doi.org/10.1177/0883073807309794
Ryan MM, Sy C, Rudge S, Ellaway C, Ketteridge D, Roddick LG et al. Dietary L-Tyrosine supplementation in nemaline myopathy. Journal of Child Neurology. 2008 Jun;23(6):609-613. https://doi.org/10.1177/0883073807309794
Ryan, Monique M. ; Sy, Catherine ; Rudge, Sian ; Ellaway, Carolyn ; Ketteridge, David ; Roddick, Laurence G. ; Iannaccone, Susan T. ; Kornberg, Andrew J. ; North, Kathryn N. / Dietary L-Tyrosine supplementation in nemaline myopathy. In: Journal of Child Neurology. 2008 ; Vol. 23, No. 6. pp. 609-613.
@article{9e8b83d6ce23440393e021374bdfd82f,
title = "Dietary L-Tyrosine supplementation in nemaline myopathy",
abstract = "Nemaline myopathy is defined by the presence of nemaline bodies, or rods, on muscle biopsy. Facial and bulbar weakness in nemaline myopathy cause chewing and swallowing difficulties, recurrent aspiration, and poor control of oral secretions. This article discusses 5 patients (4 infants and 1 adolescent) with nemaline myopathy who received dietary supplementation with L-tyrosine (250 to 3000 mg/day). All 4 infants were reported to have an initial decrease in sialorrhoea and an increase in energy levels. The adolescent showed improved strength and exercise tolerance. No adverse effects of treatment were observed. Dietary tyrosine supplementation may improve bulbar function, activity levels, and exercise tolerance in nemaline myopathy.",
keywords = "Myopathy, Nemaline, Sialorrhoea, Tyrosine",
author = "Ryan, {Monique M.} and Catherine Sy and Sian Rudge and Carolyn Ellaway and David Ketteridge and Roddick, {Laurence G.} and Iannaccone, {Susan T.} and Kornberg, {Andrew J.} and North, {Kathryn N.}",
year = "2008",
month = "6",
doi = "10.1177/0883073807309794",
language = "English (US)",
volume = "23",
pages = "609--613",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - Dietary L-Tyrosine supplementation in nemaline myopathy

AU - Ryan, Monique M.

AU - Sy, Catherine

AU - Rudge, Sian

AU - Ellaway, Carolyn

AU - Ketteridge, David

AU - Roddick, Laurence G.

AU - Iannaccone, Susan T.

AU - Kornberg, Andrew J.

AU - North, Kathryn N.

PY - 2008/6

Y1 - 2008/6

N2 - Nemaline myopathy is defined by the presence of nemaline bodies, or rods, on muscle biopsy. Facial and bulbar weakness in nemaline myopathy cause chewing and swallowing difficulties, recurrent aspiration, and poor control of oral secretions. This article discusses 5 patients (4 infants and 1 adolescent) with nemaline myopathy who received dietary supplementation with L-tyrosine (250 to 3000 mg/day). All 4 infants were reported to have an initial decrease in sialorrhoea and an increase in energy levels. The adolescent showed improved strength and exercise tolerance. No adverse effects of treatment were observed. Dietary tyrosine supplementation may improve bulbar function, activity levels, and exercise tolerance in nemaline myopathy.

AB - Nemaline myopathy is defined by the presence of nemaline bodies, or rods, on muscle biopsy. Facial and bulbar weakness in nemaline myopathy cause chewing and swallowing difficulties, recurrent aspiration, and poor control of oral secretions. This article discusses 5 patients (4 infants and 1 adolescent) with nemaline myopathy who received dietary supplementation with L-tyrosine (250 to 3000 mg/day). All 4 infants were reported to have an initial decrease in sialorrhoea and an increase in energy levels. The adolescent showed improved strength and exercise tolerance. No adverse effects of treatment were observed. Dietary tyrosine supplementation may improve bulbar function, activity levels, and exercise tolerance in nemaline myopathy.

KW - Myopathy

KW - Nemaline

KW - Sialorrhoea

KW - Tyrosine

UR - http://www.scopus.com/inward/record.url?scp=44149126988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44149126988&partnerID=8YFLogxK

U2 - 10.1177/0883073807309794

DO - 10.1177/0883073807309794

M3 - Article

C2 - 18079309

AN - SCOPUS:44149126988

VL - 23

SP - 609

EP - 613

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 6

ER -